Last reviewed · How we verify
NCT05728034
Information Seeking About Pre-exposure Prophylaxis
NA trial testing Injectable PrEP information in Pre-exposure Prophylaxis in 314 participants. Completed in 18 August 2025.
18 August 2025
Quick facts
| Lead sponsor | Penn State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 314 |
| Start date | 30 May 2023 |
| Primary completion | 18 August 2025 |
| Estimated completion | 18 August 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Injectable PrEP information
- Oral PrEP information
Conditions studied
- Pre-exposure Prophylaxis — all drugs for Pre-exposure Prophylaxis →
Sponsor
Penn State University
Who can join
Adults 18 to 34, male only, with Pre-exposure Prophylaxis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of these two intervention studies is to test promising health communication messaging strategies most likely to enhance Black, Hispanic, and non-Hispanic White YMSM's (young men who have sex with men's) engagement with online content about injectable and oral PrEP (pre-exposure prophylaxis). Participants will be asked to browse a mock Google results page featuring various kinds of PrEP information, and their browsing behavior will be unobtrusively logged. In Study 1, participants will be randomly assigned to browse for information about oral PrEP or browse for information about injectable PrEP. The design of Study 2 will be identical to Study 1 but will focus only on injectable PrEP content. In addition to browsing behavior, visual behavior data will also be collected in Study 2 with eye-trackers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05728034
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pre-exposure Prophylaxis
Currently open trials in the same condition.
- NCT06046079 — Predictors of Health Service Utilizations Among Key Population in Washington DC · recruiting
- NCT06162897 — Case Management Dyad · NA · recruiting
- NCT05856942 — Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program · NA · recruiting
- NCT05165745 — Stick2PrEP Cisgender Women and Trans Individuals · NA · recruiting
Other Penn State University trials
Trials by the same sponsor.
- NCT07147387 — Lions Hearts: A Community Approach to Multigenerational Cardiovascular Disease Risk · NA · not yet recruiting
- NCT07266506 — Development of an Eating Behavior Risk Score · NA · not yet recruiting
- NCT07229781 — Mediterranean Diet and Blood Sugar Study · NA · not yet recruiting
- NCT07235358 — Cardiometabolic Effects of Pecan Snacking in Prediabetes · NA · not yet recruiting
- NCT06823518 — Thrive Initiative Parent-Education Programming Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05728034 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Penn State University
- Last refreshed: 9 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05728034.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing